Requires registration and regulation of certain hemp-derived cannabinoids manufactured and sold in this State.

New Jersey's S 1699 requires manufacturers and retailers of hemp-derived cannabinoid products (like Delta-8-THC edibles, cosmetics, and inhalables) to register with the Cannabis Regulatory Commission, undergo mandatory safety testing, and provide clear labeling about content. The bill targets products containing hemp-derived cannabinoids with more than 0.1% concentration, aiming to address safety concerns as independent tests found some products contain unsafe THC levels or unknown compounds. Key provisions include mandatory registration, product testing for contaminants, and standardized labeling to ensure transparency for consumers. This regulation applies directly to businesses selling these products in New Jersey, moving them under the state's existing cannabis regulatory framework.